High circulating concentrations of IGFBP-3 are associated with reduced cancer risk; however, once cancer develops, IGFBP-3 levels in cancer patients drop significantly compared to levels in control groups [55,56,57]. This evidence concerns the gene IGFBP3 and cancer.